Objective: To highlight the increase in the number of cases of clonidine ov
erdose admitted to a specialist paediatric hospital, with particular refere
nce to the clinical features, clinical course and circumstances surrounding
the incident.
Methods: Cases of clonidine overdose were identified by review of the emerg
ency department attendance register, the intensive care unit database and i
npatient statistics collection. Case notes were reviewed to determine the c
linical features, history and clinical course in each case.
Results: Fifteen patients experienced 16 overdoses during the period 1990-9
7 inclusive. Only one case occurred before 1994. Depressed level of conscio
usness and bradycardia were the most common clinical manifestations, and we
re observed in 75 and 88% of cases respectively. There were no fatalities.
Five patients received naloxone. Other treatment modalities included gastro
intestinal decontamination, atropine, ventilation and inotropic support. Fo
urteen cases occurred in association with medication prescribed for attenti
on-deficit hyperactivity disorder (ADHD).
Conclusion: Clonidine overdose is a potentially serious condition, often re
quiring intensive care management. Our experience suggests that it is a gro
wing problem, related in part to its increased use in the treatment of ADHD
. Preventive strategies, including raising the level of awareness of risks,
changes to packaging and appropriate selection of patients for treatment,
need consideration if further overdoses are to be prevented.